Immunology Quiz #24: Immunosuppresant therapy

1. A 55-year-old man who recently underwent kidney transplantation is started on a medication to prevent organ rejection. This medication specifically inhibits calcineurin, thereby preventing the transcription of IL-2. Which of the following drugs is he most likely taking? 

Question 1 of 5

2. A patient with a recent liver transplant is started on a medication that binds to the FK506 binding protein, forming a complex that inhibits the enzyme mTOR, preventing T-cell proliferation. Which of the following medications was prescribed? 

Question 2 of 5

3. A 34-year-old woman with a history of systemic lupus erythematosus is prescribed a medication that selectively inhibits inosine monophosphate dehydrogenase (IMPDH), a key enzyme in the de novo synthesis of guanosine nucleotides in lymphocytes. This medication is most likely: 

Question 3 of 5

4. A patient undergoing renal transplantation is started on a medication to prevent allograft rejection. This medication is known to cause pancytopenia as an adverse effect by interfering with the synthesis of purine nucleotides. Which of the following drugs is the patient most likely taking? 

Question 4 of 5

5. A transplant patient is prescribed a medication that acts as a glucocorticoid. This drug is likely being used to: 

Question 5 of 5


¡Por tiempo limitado!

Unete a nuestro boletín mensual y obtén todos nuestros talleres USMLE/ECFMG ¡GRATIS! (+100 videos)

¡Únete a nuestra comunidad de IMGs!

¡Obtén actualizaciones mensuales USMLE y ECFMG, además, obtén un taller USMLE gratis al instante!

"Taller 01: ¿Qué es el USMLE?”

Taller Gratuito USMLE

Este taller proporciona un análisis en profundidad de todos los exámenes USMLE, consejos para tomar exámenes y cómo estudiar de manera efectiva.


Especialista ECFMG: Dr. Carla Rebeca Lainez Casal

Facultad de Medicina: Universidad Catholica de Santiago de Guayaquil
ECFMG Certification date: October 13, 2022.
Residency: 2023 Internal Medicine Applicant
+1 7542724970